针对MASLD治疗的THR-β:目前的进展和新兴前景
Jingwei Li1, Ruixian Chen2,3, Jinhang Zhang1
1Department of Pharmacy, Institute of Metabolic Diseases and Pharmacotherapy, West China Hospital, Sichuan University, Chengdu 610041, Sichuan, China.
Journal of medicinal chemistry
|January 6, 2026
概括
与代谢功能障碍相关的脂肪性肝病 (MASLD) 是一个日益严重的健康问题. 选择性甲状腺激素受体-β (THR-β) 激动剂,如Resmetirom,为MASLD提供了一个有前途的新治疗方法.
科学领域:
- 肝病学 肝病学是一种肝病学.
- 内分泌学 在内分泌学.
- 药理学 药理学是指药理学的学科.
背景情况:
- 与代谢功能障碍相关的脂肪性肝病 (MASLD) 是一个重大的全球健康挑战,有效治疗方法有限.
- 甲状腺激素受体-β (THR-β) 对肝脂代谢,炎症和纤维化至关重要,使其成为关键的治疗点.
- 以前的THR-β激动剂因系统性副作用和缺乏选择性而面临限制.
研究的目的:
- 审查MASLD的病原和当前的治疗策略.
- 阐明THR-β在肝脏健康中的作用和结构.
- 评估现有和新型THR-β激动剂用于MASLD治疗.
主要方法:
- 关于MASLD,THR-β生物学和药物治疗的科学文献的审查.
- 对THR-β激动剂的临床数据和临床前研究的分析.
- 检查选择性THR-β激动剂开发方面的进展.
主要成果:
- 通过药物化学,已经开发出具有强效的高度选择性的THR-β激动剂.
- 针对肝脏的THR-β激动剂Resmetirom (MGL-3196) 已获得FDA批准,标志着一个重大进展.
- 选择性激动剂显示出改善的治疗潜力,减少了目标外效应.
结论:
- 向THR-β代表了MASLD药物治疗的突破.
- 选择性THR-β激动剂为管理MASLD提供了一个有希望的治疗途径.
- 未来的研究应该专注于优化THR-β向疗法,以改善患者的治疗结果.
更多相关视频
11:44Cellular Membrane Affinity Chromatography Columns to Identify Specialized Plant Metabolites Interacting with Immobilized Tropomyosin Kinase Receptor B
Published on: January 19, 2022
2.9K
10:44Chemical Inactivation of the E3 Ubiquitin Ligase Cereblon by Pomalidomide-based Homo-PROTACs
Published on: May 15, 2019
13.7K
相关概念视频
02:57Targeted Cancer Therapies
8.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
8.6K
01:29Microorganisms in Medicine and Therapeutics
928
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
928
01:29Therapeutic Drug Monitoring: Affecting Factors
196
Therapeutic Drug Monitoring (TDM) is the clinical practice of measuring specific drug levels in a patient's blood or body tissues to manage and optimize therapy. TDM is crucial for drugs with narrow therapeutic windows, like warfarin and phenytoin, where incorrect doses can lead to treatment failure or severe side effects. This monitoring ensures the dosage administered is within a safe and effective range. The factors affecting therapeutic drug monitoring include:Patient-Specific Factors:a.
196